During a presentation at the health tech startup Neuralink, the richest man in the world predicted that human trials will start within six months.
According to Elon Musk, human trials for a brain chip being created by his health tech business should start within the next six months.
Musk provided updates on his company’s wireless brain chip at a presentation by Neuralink, which is run by Musk. Musk stated that in addition to predicting clinical studies, he also intends to purchase one of the chips.
According to Reuters, Musk stated, “We want to be incredibly meticulous and assured that it will operate properly before putting a gadget into a human.”
According to CNBC, Neuralink is working on brain-chip interfaces that could help people with severed spinal cords regain “full body functionality” including movement and verbal communication as well as their vision, even if they were born blind.
According to the business, human testing of the chip interface that targets the motor cortex might begin as soon as six months from now.
The Food and Drug Administration (FDA) has not given the company approval to sell the device, but Musk claimed on Wednesday that the majority of the required paperwork for FDA approval to implant the device in a human had already been submitted.
While it waits for clinical trial permission, Neuralink has been doing animal tests.
According to the New York Times, Musk said that despite prior missed deadlines, work is being made on the wireless brain chip device during the presentation to special attendees.
“The progress at first will seem perhaps agonizingly slow, particularly as it relates to humans, but we are doing all of the things to bring it to scale in parallel,” said Musk. Therefore, advancement ought to be exponential in theory.
We need your help with a simple favor. Every day, millions of people look to the Guardian for unbiased, high-quality news, and we now receive financial support from readers in 180 different nations.
We think everyone should have access to information that is based on facts and science, as well as analysis that is anchored in authority and integrity. Because of this, we took a different tack and decided to keep our reporting accessible to all readers, regardless of their location or financial situation. More people will be better informed, united, and motivated to take significant action as a result.
A global news organization that seeks the truth, like the Guardian, is crucial in these dangerous times. We are unique in that our journalism is free from commercial and political influence because we don’t have shareholders or billionaire owners. Our independence gives us the freedom to tenaciously look into, confront, and expose those in authority at a time when it has never been more crucial.